Skip to content
CVE Tracker
  • Newest CVEsPage
  • Recently added to KEVPage
  • Rising exploitation (EPSS)Page
  • Weekly digestPage
  • StatisticsPage
  • WatchlistPage
  • API documentationPage
  • Data sourcesPage
  • ChangelogPage
  • AboutPage
  • How it's builtPage
Back

CVE-2015-3956

Hospira Plum A+ Infusion System version 13.4 and prior, Plum A+3 Infusion System version 13.6 and prior, and Symbiq Infusion System,…

Critical9.8EPSS 0.95%
Published
Updated
Reserved
Assigned by
icscert

Description

Hospira Plum A+ Infusion System version 13.4 and prior, Plum A+3 Infusion System version 13.6 and prior, and Symbiq Infusion System, version 3.13 and prior accept drug libraries, firmware updates, pump commands, and unauthorized configuration changes from unauthenticated devices on the host network. Hospira recommends that customers close Port 20/FTP and Port 23/TELNET on the affected devices. Hospira has also released the Plum 360 Infusion System which is not vulnerable to this issue.

Scores

CVSS scores of CVE-2015-3956, by who scored it
Scored byCVSSScoreVector
NVDNVD · Modified3.0Critical9.8CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
EPSS (exploitation in 30 days)
0.95% · top 39% of all CVEs (4 Nov 2026)
Loading the EPSS history…

The list uses the assigner's score when there is one, then CISA's, then NVD's: Critical 9.8.

Weakness

Affected products

References (1)

Sources

The same CVE in the primary databases and aggregators, to check against.

Badge for a README or a ticket

CVE-2015-3956 badge
[![CVE-2015-3956](https://trackcve.app/badge/CVE-2015-3956.svg)](https://trackcve.app/cve/CVE-2015-3956)

Record last updated .